Posted by Michael Wonder on 23 May 2024
Advancing access to cell and gene therapies in Medicaid
22 May 2024 - The Biden administration’s stated priority to increase access to novel cell and gene therapeutics while controlling their costs culminated with the January 2024 release of the Cell and Gene Therapy Access Model by the Center for Medicare and Medicaid Innovation (CMMI).
The model seeks to test if outcomes based agreements developed by the CMMI for novel cell and gene therapies could improve access and equity while controlling costs in Medicaid.
